SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-07-003142
Filing Date
2007-05-14
Accepted
2007-05-14 16:34:47
Documents
5
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS INC. b65206ipe10vq.htm 10-Q 262734
2 EX-31.1 SECTION 302 CERTIFICATION OF CEO b65206ipexv31w1.htm EX-31.1 5845
3 EX-31.2 SECTION 302 CERTIFICATION OF CFO b65206ipexv31w2.htm EX-31.2 5857
4 EX-32.1 SECTION 906 CERTIFICATION OF CEO b65206ipexv32w1.htm EX-32.1 3065
5 EX-32.2 SECTION 906 CERTIFICATION OF CFO b65206ipexv32w2.htm EX-32.2 3045
  Complete submission text file 0000950135-07-003142.txt   282038
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 07846910
SIC: 2836 Biological Products, (No Diagnostic Substances)